TrialInternational journal of chronic obstructive pulmonary disease2015

Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial.

Chin Kook Rhee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.